$MGTA

Magenta Therapeutics Inc

  • NASDAQ
  • Health Technology
  • Biotechnology

PRICE

$1.77 -

Extented Hours

VOLUME

68,455

DAY RANGE

1.6869 - 1.83

52 WEEK

0.9231 - 8.49

Join Discuss about MGTA with like-minded investors

profile
@dros #droscrew
recently

+Initiations 1/7: $ACCD $AIRC $ARAY $ARCT $AWK $BDTX $CHTR $CVLB $DADA $EVH $INCY $INOV $KNOP $MGTA $NOG $NTST $ORTX $TDOC $TLMD $VEEV . -Initiations 1/7: $FMCC

52 Replies 15 👍 10 🔥

Key Metrics

Market Cap

104.24 M

Beta

1.41

Avg. Volume

86.02 K

Shares Outstanding

58.89 M

Yield

0%

Public Float

0

Next Earnings Date

2022-11-03

Next Dividend Date

Company Information

Magenta Therapeutics is a clinical-stage biotechnology company developing medicines to bring the curative power of immune system reset through stem cell transplant to more patients with blood cancers, genetic diseases and autoimmune diseases. Magenta is combining leadership in stem cell biology and biotherapeutics development with clinical and regulatory expertise, a unique business model and broad networks in the stem cell transplant community to revolutionize immune reset for more patients.

CEO: Jason Gardner

Website:

HQ: 100 Technology Sq Fl 5 Cambridge, 02139-3585 Massachusetts

Related News